Luitpold Animal Health Renews Commitment to AHC

Author:
Publish date:
Social count:
0

The American Horse Council (AHC) is pleased to announce that Luitpold Animal Health, a division of Luitpold Pharmaceuticals, Inc. the manufacturer of the joint therapy Adequan i.m. (polysulfated glycosaminoglycan), has continued its commitment to the horse industry by renewing its annual sponsorship for 2015.

Founded in 1969, the AHC was organized by a group of horsemen concerned about federal legislation affecting their industry. They recognized the need for national and coordinated industry action in Washington, DC. As the national association representing all segments of the horse industry in Washington, DC, the AHC works daily to represent equine interests and opportunities.

Since its inception, the AHC has been promoting and protecting the equine industry by representing its interests in Congress and in federal regulatory agencies on national issues such as taxes, health and contagious disease outbreaks, welfare issues, gaming, disaster assistance programs, immigration issues, and trail and public land use. The AHC is a non-profit organization and depends on individual membership from the horse community as well as sponsorships.

Luitpold Animal Health, manufacturer of Adequan i.m., is committed to advancing the cause of better animal health through scientifically proven and FDA-approved products. “Our support of the American Horse Council continues to be paramount concerning the future of the equine industry,” stated Allyn Mann, Director at Luitpold Animal Health. “It is the only forum that brings all segments of the industry together to discuss vital issues related to the present and future of the equine industry. I would encourage any company that is involved in the equine industry to support the American Horse Council.”

Maintaining the health and soundness of equine athletes is one of the keys to their success. Adequan i.m. is a veterinarian-trusted name in the treatment against equine degenerative joint disease, and is the only FDA-approved intramuscular polysulfated glycosaminoglycan for use in the equine. Treatment with Adequan i.m. has been shown to stop the destructive disease cycle, reverse non-infectious degenerative joint disease and improve joint function. If you suspect your equine athlete or companion horse is experiencing non-infectious degenerative joint disease, speak to your veterinarian and find out if Adequan i.m., “The Winning Formula for Champions,” can benefit your horse.

Luitpold has been a strong supporter of the AHC since 2008, and has proven that it is committed in helping ensure the success and growth of the entire horse industry in the United States. “It is a real pleasure to see how committed Luitpold Pharmaceuticals is to the issues that we work on. Allyn Mann came to Capitol Hill to lobby with us during our annual meeting last year. It is great to know that we have such dedicated support,” said James Hickey, president of the AHC.

As part of its 2015 sponsorship of the AHC, Luitpold will be sponsoring the Council’s National Issues Forum on June 16th for the seventh year in a row. The National Issues Forum focuses on the health, welfare, and integrity of the horse and horse industry and is attended by hundreds of leaders in the horse industry.

For more information about Luitpold Animal Health visit http://www.luitpoldanimalhealth.com/.

For more information about Adequan i.m. visit www.adequan.com.

Adequan® i.m. Brief Summary Indications: For the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. There are no known contraindications to the use of intramuscular Adequan®i.m. brand Polysulfated Glycosaminoglycan in horses. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Each 5 mL contains 500 mg Polysulfated Glycosaminoglycan. SEE PRODUCT PACKAGE INSERT FOR FULL PRESCRIBING INFORMATION at www.adequan.com. Adequan is a registered trademark of Luitpold Pharmaceuticals, Inc. LUITPOLD PHARMACEUTICALS, INC., Animal Health Division, Shirley, NY 11967.

As the national association representing all segments of the horse industry in Washington, D.C., the American Horse Council works daily to represent equine interests and opportunities. The AHC promotes and protects the industry by communicating with Congress, federal agencies, the media and the industry on behalf of all horse related interests each and every day. The AHC is member supported by individuals and organizations representing virtually every facet of the horse world from owners, breeders, veterinarians, farriers, breed registries and horsemen's associations to horse shows, race tracks, rodeos, commercial suppliers and state horse councils.